Search Ontology:
ChEBI

selinexor

Term ID
CHEBI:229764
Synonyms
  • (2Z)-3-{3-[3,5-bis(trifluoromethyl)phenyl]-1H-1,2,4-triazol-1- yl}-N'-(pyrazin-2-yl)prop-2-enehydrazide
  • (2Z)-3-{3-[3,5-bis(trifluoromethyl)phenyl]-1H-1,2,4-triazol-1-yl}-N'-(pyrazin-2-yl)prop-2-enehydrazide
  • KPT 330
  • KPT-330
  • selinexor
  • selinexorum
  • Xpovio
Definition
A member of the class of triazoles that is 1H-1,2,4-triazole substituted by (1Z)-3-oxo-3-[2-(pyrazin-2-yl)hydrazinyl]prop-1-en-1-yl and 3,5-bis(trifluoromethyl)phenyl groups at positions 1 and 3, respectively. It is a prescription medicine approved for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma.
References
  • drugbank:DB11942
  • hmdb:HMDB0258217
  • kegg.drug:D11222
  • pubmed:23373539
  • pubmed:27893412
  • pubmed:28314790
  • pubmed:28810913
  • pubmed:28852098
  • pubmed:29707241
  • pubmed:30064906
  • pubmed:30115935
  • pubmed:30996012
  • pubmed:32598257
  • pubmed:33403670
  • pubmed:33507295
  • pubmed:33601919
  • pubmed:34488662
  • pubmed:34669417
  • pubmed:34741230
  • pubmed:35355406
  • pubmed:35477814
  • pubmed:35667526
  • pubmed:35941226
  • pubmed:36180918
  • pubmed:36200270
  • pubmed:36622814
  • pubmed:36731340
  • pubmed:36827679
  • pubmed:36847599
  • pubmed:37016732
  • pubmed:37046649
  • pubmed:37047788
  • pubmed:37079389
  • pubmed:37094850
  • pubmed:37126200
  • pubmed:37175668
  • pubmed:37184196
  • pubmed:37191210
  • pubmed:37346402
  • pubmed:37595020
  • pubmed:37715291
  • pubmed:37760508
  • pubmed:37945593
  • pubmed:38105606
  • pubmed:38186637
  • pubmed:38454813
  • wikipedia.en:Selinexor
Ontology
ChEBI  ( EBI )
Relationships
Phenotype
Phenotype resulting from selinexor
Phenotype where environments contain selinexor
Phenotype modified by environments containing selinexor
Phenotype affecting selinexor
Human Disease Model